CVS CVS HealthcompanySEC Filings & Insider Trading Activity 2026
Latest CVS Health (CVS) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 10, 2026, a 10-Q quarterly report filed on October 29, 2025, an 8-K current report filed on March 19, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for CVS Health (CVS) (SEC CIK 64803), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business risk focus on compliance with extensive laws, regulations, and contractual requirements in healthcare sectors
- • Increased litigation exposure due to vertical integration strategy and expanded healthcare services
Risk Factors
- • Opioid litigation risk: $320 million accrual increase for ongoing opioid litigation matters in 2025
- • Geopolitical/macroeconomic exposure: Medicare Advantage segment served 37 million people, sensitive to CMS policy changes
Management Discussion & Analysis
- • No revenue or profitability data disclosed in this MD&A section
- • Market valuation risk: $3.6B fair value decline in long-term debt with 100bp rate increase; no impact on operations
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • No financial data or segment performance disclosed in the provided MD&A excerpt
- • Forward-looking statements caution under Reform Act, no updated guidance or outlook given
Risk Factors
- • No material changes to risk factors compared to 10-K, risks carried forward without update
- • COVID-19 pandemic impact on operations and supply chain remains significant near-term operational risk
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • John E. Gallina, former CFO of Elevance Health (2016-2023), appointed to CVS Health Board effective March 19, 2026
- • Gallina named to Audit Committee, designated audit committee financial expert under SEC rules
Annual Reports Archive10-K
AI-powered analysis of CVS Health (CVS) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of CVS Health (CVS) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of CVS Health (CVS) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $322.5B | $357.8B | $372.8B | $402.1B |
| Operating Income | $7.7B | $13.7B | $8.5B | $4.7B |
| Net Income | $4.1B | $8.3B | $4.6B | $1.8B |
| Op. Margin | 2.4% | 3.8% | 2.3% | 1.2% |
| Net Margin | 1.3% | 2.3% | 1.2% | 0.4% |
| Balance Sheet | ||||
| Total Assets | $228.3B | $249.7B | $253.2B | $253.5B |
| Equity | $71.0B | $76.5B | $75.6B | $75.2B |
| ROE | 5.8% | 10.9% | 6.1% | 2.4% |
Source: XBRL financial data from CVS Health (CVS) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 19, 2026 | — | Analysis | — |
8-K | Feb 10, 2026 | — | — | |
10-K | Feb 10, 2026 | Dec 31, 2025 | Analysis | |
8-K | Dec 9, 2025 | — | — | |
10-Q | Oct 29, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 31, 2025 | Jun 30, 2025 | Analysis | |
10-Q | May 1, 2025 | Mar 31, 2025 | Analysis | |
10-K | Feb 12, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | — | |
10-Q | May 1, 2024 | Mar 31, 2024 | — | |
10-K | Feb 7, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 3, 2023 | Mar 31, 2023 | — | |
10-K | Feb 8, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 3, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-K | Feb 9, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 4, 2021 | Jun 30, 2021 | — | |
10-Q | May 4, 2021 | Mar 31, 2021 | — | |
10-K | Feb 16, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 6, 2020 | Sep 30, 2020 | — |
Frequently Asked Questions
What are the latest CVS SEC filings in 2026?
CVS Health (CVS) has filed a 10-K annual report on February 10, 2026, a 10-Q quarterly report on October 29, 2025, an 8-K current report on March 19, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CVS file its most recent 10-K annual report?
CVS Health (CVS) filed its most recent 10-K annual report on February 10, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CVS 10-Q quarterly reports?
CVS Health (CVS)'s most recent 10-Q quarterly report was filed on October 29, 2025. SignalX displays every CVS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CVS filed recently?
CVS Health (CVS)'s most recent 8-K was filed on March 19, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CVS insider trading activity (Form 4)?
SignalX aggregates every CVS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CVS file with the SEC?
CVS Health (CVS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CVS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for CVS Health (CVS).
What is CVS's SEC CIK number?
CVS Health (CVS)'s SEC CIK (Central Index Key) number is 64803. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 64803 to look up all CVS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CVS return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from CVS Health (CVS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of CVS Health SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 37+ filings.